Private equity firm JLL Patheon Holdings went ahead yesterday with its unsolicited $2-per-share bid for Patheon that would take the company into private ownership... Read

The slashing of pharma's in-house teams did not help contract sales provider PDII in 2008, with the company recording an operating loss of $36.4m (€28.5m), compared with a $14.3m deficit the previous year... Read

US contract research organisation ACM Global Central Laboratory has bought its longstanding business partner Pivotal Laboratories of the UK in a bid to boost its international reach... Read

German coating technology specialist Driam hopes its new Driaconti-T continuous tablet coating platform will win over manufacturers wishing to improve process efficiency in times of economic gloom... Read

BioFocus DPI, the service division of Belgian drug discovery firm Galapagos, made a profit of €3.4m on revenues a little over €56m in 2008, reversing a loss of about the same magnitude in 2007... Read

The backlash against the re-importation bill has begun, with PhRMA warning that the legislation could cripple the FDA's ability to protect patients and open the door to counterfeits... Read

Drug giants Pfizer and GSK may be among the first affected by last week's US Supreme Court ruling upholding a product liability lawsuit against Wyeth despite FDA approved labelling... Read

Following the proposal of his bill re-importation bill Senator Byron Dorgan has accused some of big pharma of taking actions that would be illegal under the Act and outlined the punishments they could face... Read

The FDA has found "significant objectionable conditions" at the Genzyme manufacturing facility that makes Lumizyme, creating another issue in the product's approval process... Read

Belgian biopharmaceutical company UCB has contracted Proteros Biostructures of Germany to provide support in the structure-based discovery of small-molecule drugs... Read

UK CRO Richmond Pharmacology has unveiled a new data management offering for the drug industry that it claims will help trial sponsors cut costs, save time and help guarantee data integrity... Read

Outsourcing-Pharma.com presents its periodic round-up of executive appointments in the contract services sector and pharmaceutical industry... Read

eClinical company etrials saw losses increase in the fourth quarter of 2008, but pointed to a healthy increase in orders as evidence of the underlying strength of the business... Read

Patheon chief Wes Wheeler says the drop in Q1 losses the firm recently reported is due to the "restructuring activities and rigorous cost containment efforts" it enacted towards the end of last year... Read